Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

Clinical trial NCT04930653 · SUSPENDED

Trial details

NCT number: NCT04930653
Sponsor: City of Hope Medical Center
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Folliculotropic Mycosis Fungoides Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Sezary Syndrome Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8 Transformed Mycosis Fungoides

Start date: 2022-10-19
Primary completion: 2028-06-15
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.